A Phase 2, Multicenter, Randomized, Double Blind, Placebo Controlled, Parallel Group, Dose Range Finding Study to Evaluate the Efficacy and Safety of X0002 Spray Versus Placebo in Subjects With Osteoarthritis
Phase of Trial: Phase II
Latest Information Update: 09 Feb 2018
Price : $35 *
At a glance
- Drugs Ibuprofen (Primary)
- Indications Osteoarthritis
- Focus Therapeutic Use
- 05 May 2016 Status changed from active, no longer recruiting to completed.
- 31 Mar 2016 Planned End Date changed from 1 Jun 2015 to 1 May 2016 as reported by ClinicalTrials.gov.
- 25 Mar 2015 Planned primary completion date changed from 1 Jan 2015 to 1 May 2015, as reported by ClinicalTrials.gov.